Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms PG6 |
Target |
Action degraders |
Mechanism GSK-3β degraders(Glycogen synthase kinase-3 beta degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H30N6O7S |
InChIKeyWQUDMZPFXBSLGK-UHFFFAOYSA-N |
CAS Registry2408584-94-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Preclinical | China | 01 Jan 2021 |